News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sprout Group Announces $12 Million Financing In Sopherion Therapeutics, Inc.



10/19/2005 5:10:55 PM

Sprout Group announced today that the Company has invested $12 million as part of a $47 million Series B Financing in Sopherion Therapeutics, Inc., a biopharmaceutical company focusing on the development and commercialization of anti-cancer therapies. In addition to Sprout Group's financing and a lead investment by TL Ventures, the remainder of the funding came from ProQuest, Canaan Partners, HealthCap, NewSpring Ventures, L.P., Commerce Health Ventures, and Seaflower Ventures.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES